2021-06-07-世界卫生组织-INN_Proposed_List_125_-COVID-_4页_163kb

World Health Organization Drug Information announces Proposed International Nonproprietary Names (INN) for COVID-19-related substances. Specifically, List 125 features "elasomeranum" as a proposed name for an mRNA vaccine component targeting SARS-CoV-2 spike protein, intended for active immunization. This name is provisional and open for public consultation for one month, shortened due to pandemic circumstances, with comments to be submitted by July 9, 2021. WHO does not recommend use, only proposes the name for consideration.